X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indoco Remedies Fact Sheet, Indoco Remedies Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Fact Sheet   (INDOCO)

Here is the latest financial fact sheet of Indoco Remedies. For more details, see the Indoco Remedies quarterly results and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

INDOCO REMEDIES Price History

Price Rs 218.0
Mkt Cap Rs m 20,090
Vol '000 0.1
P/E X 86.0
P/CF X 14.3
EPS (TTM) Rs 2.5
% ch % 1.0
No. of shares m 92.18
% ch week % 1.0
% ch 1-mth % 17.1
% ch 12-mth % -19.5
52 week H/L Rs 317.0/150.3
(As on Dec 13, 2018 11:41:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDOCO REMEDIES Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
INDOCO REMEDIES EQUITY SHARE DATA
High Rs83162378412360 
Low Rs5155131263249 
Sales per share (Unadj.) Rs68.579.593.0109.4119.0 
Earnings per share (Unadj.) Rs4.66.39.08.98.4 
Diluted earnings per shareRs4.66.39.08.98.4 
Cash flow per share (Unadj.) Rs7.29.614.115.515.2 
Dividends per share (Unadj.) Rs1.101.401.601.601.60 
Adj. dividends per shareRs1.101.401.601.601.60 
Dividend yield (eoy) %1.61.30.60.50.5 
Book value per share (Unadj.) Rs44.949.657.362.670.7 
Adj. book value per shareRs44.949.657.362.570.7 
Shares outstanding (eoy) m92.1592.1592.1592.1592.15 
Bonus/Rights/Conversions  FV2, B1:2---- 
Price / Sales ratio x1.01.42.73.12.6 
Avg P/E ratio x14.517.228.337.936.4 
P/CF ratio (eoy) x9.311.218.021.820.0 
Price / Book Value ratio x1.52.24.45.44.3 
Dividend payout %23.722.217.818.019.1 
Avg Mkt Cap Rs m6,1749,98923,43831,08728,083 
No. of employees `000NANANA5.76.0 
Total wages/salary Rs m1,0791,2951,4001,8192,167 
Avg. sales/employee Rs ThNMNMNM1,762.41,817.0 
Avg. wages/employee Rs ThNMNMNM318.0359.0 
Avg. net profit/employee Rs ThNMNMNM143.3127.7 
INDOCO REMEDIES INCOME DATA
Net Sales Rs m6,3087,3268,57010,08110,968 
Other income Rs m1518171640 
Total revenues Rs m6,3237,3448,58710,09711,007 
Gross profit Rs m9261,2041,6551,7041,565 
Depreciation Rs m237309471607633 
Interest Rs m21918910612462 
Profit before tax Rs m4867231,096989909 
Minority Interest Rs m0-1000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m58143267170139 
Profit after tax Rs m427580828819771 
Gross profit margin %14.716.419.316.914.3 
Effective tax rate %11.919.824.417.215.3 
Net profit margin %6.87.99.78.17.0 
INDOCO REMEDIES BALANCE SHEET DATA
Current assets Rs m2,7553,0463,8904,6465,725 
Current liabilities Rs m1,9932,0222,9263,6415,454 
Net working cap to sales %12.114.011.310.02.5 
Current ratio x1.41.51.31.31.0 
Inventory Days Days5455646062 
Debtors Days Days7469666872 
Net fixed assets Rs m3,5923,6944,0224,2965,307 
Share capital Rs m184184184184184 
"Free" reserves Rs m3,9504,3805,0935,5816,331 
Net worth Rs m4,1424,5725,2775,7656,516 
Long term debt Rs m2741381293791,323 
Total assets Rs m6,9197,2948,2039,40611,970 
Interest coverage x3.24.811.49.015.6 
Debt to equity ratio x0.1000.10.2 
Sales to assets ratio x0.91.01.01.10.9 
Return on assets %9.310.511.410.07.0 
Return on equity %10.312.715.714.211.8 
Return on capital %15.919.422.218.112.4 
Exports to sales %33.533.936.240.10 
Imports to sales %5.45.47.57.70 
Exports (fob) Rs m2,1162,4803,1014,0440 
Imports (cif) Rs m3433966437730 
Fx inflow Rs m2,1162,4803,1014,0444,507 
Fx outflow Rs m4455498191,0171,141 
Net fx Rs m1,6711,9312,2823,0273,366 
INDOCO REMEDIES CASH FLOW
From Operations Rs m 687 988 1,090 1,122 886 
From Investments Rs m -426 -410 -884 -1,107 -1,706 
From Financial Activity Rs m -244 -590 -199 -16 1,316 
Net Cashflow Rs m 17 -12 7 -1 497 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 59.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 12.5%
FIIs 6.0%
ADR/GDR 0.0%
Free float 22.4%
Shareholders 12,805
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 166, Indoco House, CST Road, kalina, Santacruz (E), Mumbai - 400 098
E-MAIL sunil.joshi@indoco.com WEB www.indoco.com
TELEPHONE (022) 2654 1851 FAX (022) 2652 3067
SECTOR MISCELLANEOUS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Patkar & Pendse
CHM: Suresh G. Kare (MD) COMP SEC: Sunil D. Joshi YEAR OF INC: 1945 BSE CODE: 532612 FV (Rs): 2 DIV YIELD (%): 0.7

More Miscellaneous Company Fact Sheets:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NATCO PHARMA  FDC LTD.  

Compare INDOCO REMEDIES With:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  AUROBINDO PHARMA  NATCO PHARMA  FDC LTD.  

Compare INDOCO REMEDIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Strong; PSU & Realty Stocks Lead(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 1.3%.

Views on news

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - GEOJIT FINANCIAL SERVICES COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS